Reported 2 days ago
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) stands out among stocks with significant upside potential, offering a 138% increase possibility. As a developer of neffy, a needle-free epinephrine nasal spray designed for severe allergic reactions, the company has seen solid early demand and promising partnerships, putting it in a favorable position within a multi-billion-dollar market. This article discusses challenges and opportunities in the market alongside other unstoppable stocks that could double investors’ money.
Source: YAHOO